论文部分内容阅读
Oral cancer is the eighth most common cancer worldwide with an overall 5-year survival rate of less than 50%.Precise differentiation of benign and malignant tumors plays key roles in proper and timely selection of the therapeutic treatment.This study will pay more attention to screening valuable markers by comparing a more complete metabolite profiles in the relevant biofluids (plasma, urine and saliva) from the control, benign and malignant oral tumor patients.